Jafra - 68828-106-02 - (Titanium Dioxide, Octinoxate)

Alphabetical Index


Drug Information of Jafra

Product NDC: 68828-106
Proprietary Name: Jafra
Non Proprietary Name: Titanium Dioxide, Octinoxate
Active Ingredient(s): 2; 6.4    mL/80mL; mL/80mL & nbsp;   Titanium Dioxide, Octinoxate
Administration Route(s): TOPICAL
Dosage Form(s): LIQUID
Coding System: National Drug Codes(NDC)

Labeler Information of Jafra

Product NDC: 68828-106
Labeler Name: Jafra Cosmetics International Inc
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: part352
Marketing Category: OTC MONOGRAPH NOT FINAL
Start Marketing Date: 20120730

Package Information of Jafra

Package NDC: 68828-106-02
Package Description: 10 BOTTLE in 1 PACKAGE (68828-106-02) > 8 mL in 1 BOTTLE (68828-106-01)

NDC Information of Jafra

NDC Code 68828-106-02
Proprietary Name Jafra
Package Description 10 BOTTLE in 1 PACKAGE (68828-106-02) > 8 mL in 1 BOTTLE (68828-106-01)
Product NDC 68828-106
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Titanium Dioxide, Octinoxate
Dosage Form Name LIQUID
Route Name TOPICAL
Start Marketing Date 20120730
Marketing Category Name OTC MONOGRAPH NOT FINAL
Labeler Name Jafra Cosmetics International Inc
Substance Name OCTINOXATE; TITANIUM DIOXIDE
Strength Number 2; 6.4
Strength Unit mL/80mL; mL/80mL
Pharmaceutical Classes

Complete Information of Jafra


General Information